MedPath

Topiramate

These highlights do not include all the information needed to use TOPIRAMATE CAPSULES safely and effectively. See full prescribing information for TOPIRAMATE CAPSULES TOPIRAMATE capsules, for oral use Initial U.S. Approval: 1996

Approved
Approval ID

e0d88f34-865c-441b-80e2-e814c9a7d670

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 5, 2023

Manufacturers
FDA

TWi Pharmaceuticals, Inc.

DUNS: 658402052

FDA

Upsher-Smith Laboratories, LLC

DUNS: 047251004

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Topiramate

PRODUCT DETAILS

NDC Product Code24979-210
Application NumberANDA217694
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 6, 2023
Generic NameTopiramate

INGREDIENTS (7)

TOPIRAMATEActive
Quantity: 15 mg in 1 1
Code: 0H73WJJ391
Classification: ACTIB
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
CELLULOSE ACETATEInactive
Code: 3J2P07GVB6
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT

Topiramate

PRODUCT DETAILS

NDC Product Code24979-211
Application NumberANDA217694
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 6, 2023
Generic NameTopiramate

INGREDIENTS (7)

POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
TOPIRAMATEActive
Quantity: 25 mg in 1 1
Code: 0H73WJJ391
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CELLULOSE ACETATEInactive
Code: 3J2P07GVB6
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Topiramate - FDA Approval | MedPath